Skip to main content
Log in

Bevacizumab/paclitaxel

Neuropathy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. In the study, additional paclitaxel on day 8 for the initial 2 or 3 cycles was given to patients with emerging disease [ it is unclear whether this patient received additional paclitaxel].

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/paclitaxel. Reactions Weekly 1542, 49 (2015). https://doi.org/10.1007/s40278-015-8457-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8457-z

Navigation